Howard Hughes Medical Institute’s Broadcom AVGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.6M Hold
65,028
5.52% 7
2026
Q1
$20.1M Buy
65,028
+64,012
+6,300% +$21.1M 4.84% 8
2025
Q4
$352K Buy
1,016
+5
+0.5% +$1.79K 0.2% 7
2025
Q3
$334K Hold
1,011
0.2% 7
2025
Q2
$279K Buy
+1,011
New +$220K 0.11% 7
2017
Q3
Sell
-59,250
Closed -$1.38M 40
2017
Q2
$1.38M Sell
59,250
-13,010
-18% -$302K 0.25% 62
2017
Q1
$1.58M Sell
72,260
-5,450
-7% -$112K 0.29% 65
2016
Q4
$1.37M Sell
77,710
-75,570
-49% -$1.31M 0.31% 61
2016
Q3
$2.64M Buy
153,280
+3,780
+3% +$63.2K 0.68% 42
2016
Q2
$2.32M Sell
149,500
-160,910
-52% -$2.45M 0.78% 46
2016
Q1
$4.8M Buy
310,410
+219,980
+243% +$2.97M 1.06% 21
2015
Q4
$1.31M Buy
90,430
+25,480
+39% +$331K 0.2% 63
2015
Q3
$812K Buy
+64,950
New +$821K 0.15% 77

Other funds holding AVGO

Howard Hughes Medical Institute's AVGO Position: Q2 2026 in Review

Howard Hughes Medical Institute held its Broadcom (AVGO) position steady in Q2 2026 at 65,028 shares worth $24.6M. The position accounts for 5.52% of the portfolio, ranked #7.

Howard Hughes Medical Institute first reported a position in AVGO in Q3 2015 and has held it in 13 quarters since. 4,819 funds tracked by Wall St. Rank hold AVGO as of Q2 2026.

  • Howard Hughes Medical Institute held 65,028 shares of Broadcom worth $24.6M as of Q2 2026.
  • Howard Hughes Medical Institute left its Broadcom share count unchanged in Q2 2026.
  • Broadcom made up 5.52% of Howard Hughes Medical Institute's portfolio in Q2 2026, its #7 holding.
  • Howard Hughes Medical Institute first reported a position in Broadcom in Q3 2015 and has held it in 13 quarters since.
  • 4,819 funds tracked by Wall St. Rank held Broadcom as of Q2 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2026, filed 14 Aug 2026.